Illinois 2023-2024 Regular Session

Illinois Senate Bill SR0079 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	SR0079LRB103 05551 ECR 50570 r SR0079 LRB103 05551 ECR 50570 r
2	2	SR0079 LRB103 05551 ECR 50570 r
3	3	1 SENATE RESOLUTION
4	4	2 WHEREAS, Hypertrophic Cardiomyopathy (HCM) is a chronic
5	5	3 cardiovascular disease involving thickening of the heart
6	6	4 muscle and can potentially lead to debilitating symptoms and
7	7	5 serious complications, including heart failure, atrial
8	8	6 fibrillation, stroke, and, in rare cases, sudden cardiac
9	9	7 death; and
10	10	8 WHEREAS, HCM is the most common inheritable heart disease
11	11	9 and can affect anyone regardless of age, gender, or ethnicity
12	12	10 with a reported prevalence ranging from 1 in 200 to 1 in 500 in
13	13	11 the general population; and
14	14	12 WHEREAS, An estimated 700,000 to 1,650,000 people in the
15	15	13 United States have HCM, yet 85% of them may remain
16	16	14 undiagnosed; and
17	17	15 WHEREAS, HCM shares symptoms with other common
18	18	16 cardiovascular and pulmonary diseases, including shortness of
19	19	17 breath, chest pain, fatigue, palpitations, and fainting; this
20	20	18 makes it difficult to distinguish HCM from these other
21	21	19 diseases; and
22	22	20 WHEREAS, All-cause mortality risk is three to four times
23	23	21 higher in patients with HCM than that of the general
24	24
25	25
26	26
27	27	SR0079 LRB103 05551 ECR 50570 r
28	28
29	29
30	30	SR0079- 2 -LRB103 05551 ECR 50570 r SR0079 - 2 - LRB103 05551 ECR 50570 r
31	31	SR0079 - 2 - LRB103 05551 ECR 50570 r
32	32	1 population; and
33	33	2 WHEREAS, Knowing one's medical history and any signs and
34	34	3 symptoms of HCM are important first steps in receiving an
35	35	4 accurate diagnosis of HCM; and
36	36	5 WHEREAS, A healthcare provider must conduct a thorough
37	37	6 screening with cardiac health questions to help identify a
38	38	7 risk of both genetic and congenital cardiac disorders; and
39	39	8 WHEREAS, A healthcare provider may conduct several tests,
40	40	9 including an echocardiogram, a cardiac MRI, or genetic
41	41	10 testing, to confirm a family history of HCM and must examine
42	42	11 the heart to diagnose HCM; and
43	43	12 WHEREAS, Following a diagnosis of HCM, it is important for
44	44	13 patients to work with their healthcare provider to learn more
45	45	14 about their disease and understand different management
46	46	15 options, including prescription medicines and surgical
47	47	16 treatment options that may help; and
48	48	17 WHEREAS, The fourth Wednesday in February is an
49	49	18 appropriate day to observe Hypertrophic Cardiomyopathy
50	50	19 Awareness Day; therefore, be it
51	51	20 RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL
52	52
53	53
54	54
55	55
56	56
57	57	SR0079 - 2 - LRB103 05551 ECR 50570 r
58	58
59	59
60	60	SR0079- 3 -LRB103 05551 ECR 50570 r SR0079 - 3 - LRB103 05551 ECR 50570 r
61	61	SR0079 - 3 - LRB103 05551 ECR 50570 r
62	62	1 ASSEMBLY OF THE STATE OF ILLINOIS, that we declare February
63	63	2 22, 2023 as Hypertrophic Cardiomyopathy Awareness Day in the
64	64	3 State of Illinois in order to raise public awareness about
65	65	4 hypertrophic cardiomyopathy, a serious public health issue;
66	66	5 and be it further
67	67	6 RESOLVED, That we acknowledge the critical importance of
68	68	7 hypertrophic cardiomyopathy awareness to improve
69	69	8 cardiovascular health in the state and support raising
70	70	9 awareness of the consequences of undiagnosed and untreated
71	71	10 hypertrophic cardiomyopathy and of the need to seek
72	72	11 appropriate care for hypertrophic cardiomyopathy; and be it
73	73	12 further
74	74	13 RESOLVED, That we respectfully urge the Governor to issue
75	75	14 an annual proclamation recognizing the fourth Wednesday in
76	76	15 February as Hypertrophic Cardiomyopathy Awareness Day and call
77	77	16 upon the people of Illinois to observe the day with
78	78	17 appropriate programs and activities.
79	79
80	80
81	81
82	82
83	83
84	84	SR0079 - 3 - LRB103 05551 ECR 50570 r